Global Hospital-Acquired Infection Control Market 2017-2021
- SKU ID : TNV-IRTNTR13353 10886150
- |
- Publishing Date: 05-Jul-2017
- |
- Region: Global
- |
- No. of pages: 94
About Hospital-Acquired Infection Control
HAIs, which are also called nosocomial infections, refer to a collection of conditions that a patient may develop when being treated in hospitals or other healthcare facilities. Modern healthcare settings use multiple devices to treat patients. These can be breeding grounds for microorganisms, which can have adverse effects on patient health. HAIs have caused a significant cost burden on patients and healthcare facilities.
Technavio’s analysts forecast the global hospital-acquired infection control market to grow at a CAGR of 4.81% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global hospital-acquired infection control market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of HAI products.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Hospital-Acquired Infection Control Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• AstraZeneca
• GlaxoSmithKline
• Merck
• Pfizer
Other prominent vendors
• 3M
• Abbott Laboratories
• AbbVie
• Advanced Sterilization Products
• Alere
• Bayer
• BD
• bioMérieux
• Cepheid
• Getinge Group
• Hoffmann La-Roche
• Synergy Health
• Xenex
Market driver
• Increasing innovative measures to prevent HAIs
• For a full, detailed list, view our report
Market challenge
• Emergence of antibiotic resistance
• For a full, detailed list, view our report
Market trend
• Emergence of innovative techniques to remove biofilms
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
HAIs, which are also called nosocomial infections, refer to a collection of conditions that a patient may develop when being treated in hospitals or other healthcare facilities. Modern healthcare settings use multiple devices to treat patients. These can be breeding grounds for microorganisms, which can have adverse effects on patient health. HAIs have caused a significant cost burden on patients and healthcare facilities.
Technavio’s analysts forecast the global hospital-acquired infection control market to grow at a CAGR of 4.81% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global hospital-acquired infection control market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of HAI products.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Hospital-Acquired Infection Control Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• AstraZeneca
• GlaxoSmithKline
• Merck
• Pfizer
Other prominent vendors
• 3M
• Abbott Laboratories
• AbbVie
• Advanced Sterilization Products
• Alere
• Bayer
• BD
• bioMérieux
• Cepheid
• Getinge Group
• Hoffmann La-Roche
• Synergy Health
• Xenex
Market driver
• Increasing innovative measures to prevent HAIs
• For a full, detailed list, view our report
Market challenge
• Emergence of antibiotic resistance
• For a full, detailed list, view our report
Market trend
• Emergence of innovative techniques to remove biofilms
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
